fda approves first oral glp-1 obesity drug august 21 2025 US Wegovy Pill for Weight Loss US regulators approve Wegovy pill,

Steven Klein reports preclinical success in a trial of 130 patients

Immune modulation The evidence for GLP-1 signaling in immune function stems from studying the physiological response to inflammation, where GLP-1 release increases in rodent inflammation models and in humans with systemic inflammation, where it correlates with interleukin (IL)-6 levels, and in a murine anti-CD3 model of intestinal inflammation, where GLP-1R expression is upregulated

However, while these medications have helped many people take control of their health, they can also come with side effects that make the journey more difficult

Park, J.-S

This new drug could have similar serious side effects and result in similar lawsuits